
Lexaria Bioscience Corp.
NASDAQ:LEXX
1.06 (USD) • At close May 8, 2025
Overzicht | Financiële gegevens
Bedrijfsnaam | Lexaria Bioscience Corp. |
Symbool | LEXX |
Munteenheid | USD |
Prijs | 1.08 |
Beurswaarde | 21,042,936 |
Dividendpercentage | 0% |
52-weken bereik | 1.02 - 4.44 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Mr. Christopher A. Bunka |
Website | https://www.lexariabioscience.com |
An error occurred while fetching data.
Over Lexaria Bioscience Corp.
Lexaria Bioscience Corp. operates as a biotechnology company. Its patented drug delivery technology, DehydraTECH, improves the way active pharmaceutical ingredients enter the bloodstream by promoting effective oral delivery. The company's DehydraTECH has demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x and in some instances with cannabinoids
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)